Pharma & Biotech

Precision Biosciences is progressing its gene therapy candidate for Duchenne muscular dystrophy (DMD), with investor attention now turning to a...

The biotechnology firm Codexis is transitioning its operations from a research-focused phase to establishing industrial production capabilities. Central to this...

The biotechnology firm Allogene Therapeutics is approaching a critical juncture that will test the long-term viability of its business model....

Biotechnology firm Xilio Development is set to present new preclinical findings for its drug candidate XTX601 at the upcoming American...

New clinical data presented this week by Arvinas at a specialist conference in Copenhagen has marked a significant advance for...

The dissolution of biotechnology firm Vyant Bio continues to proceed at a slower pace than initially outlined. While shareholders approved...

The investment thesis for biopharmaceutical company Ocugen is gaining notable support on Wall Street. In a significant endorsement, the firm...

Today marks a significant confluence of events for Healwell AI Inc. The company is releasing its complete fiscal 2025 annual...

French vaccine specialist Valneva has unveiled its full-year 2025 results, presenting a nuanced financial picture that underscores a significant improvement...

The biotech firm Ocugen has staged a remarkable recovery in recent months, capturing renewed attention from institutional investors. This resurgence...